Purity, integrity, and potency: solving the analytical challenges of mRNA-LNP drug development

mRNA-based therapeutics and vaccines succeed or fail on analytical rigour. As lipid nanoparticles (LNPs) become the delivery vehicle of choice, two challenges are converging: ionizable lipids prone to potency-eroding N-oxidation, and RNA payloads growing too large and too complex for conventional tools such as capillary electrophoresis.

This collection brings together three expert webinars and an interactive Tech Showcase covering advanced mass spectrometry for ionizable lipid purity, next-generation RNA characterization for base-modified and self-replicating constructs, and end-to-end quality assessment across IVT mRNA production.

Complete a single registration form to unlock all four pieces of content.